Income Statement Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Real-time Estimate Cboe BZX Other stock markets 10:25:58 09/07/2025 pm IST			5-day change	1st Jan Change
235.94 ^USD	-0.65%		-3.22%	-7.00%

03/07	Centene shares plunge after health insurer withdraws forecast over Obamacare concerns	RE
02/07	Sector Update: Health Care Stocks Decline Wednesday Afternoon	MT

1a98e404ac396824f8317b5926.WWBmbETShj8Phy446riJo-g3WjOjwPS6HanyQ1y_owA.FFIwOzW802U2yUsMi_7q6690IAbU8a7dL56oNz3N1mhqAhwpIbC-Dl22RQ

Published financial data: HUMANA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	7.42TCr	7.98TCr	8.77TCr	10TCr	11TCr
Total Interest And Dividend Income	32Cr	32Cr	59Cr	112.3Cr	120.2Cr
Gain (Loss) on Sale of Investments, Total (Rev)	84Cr	100Cr	-20Cr	-5.4Cr	2.4Cr
Other Revenues, Total	181.5Cr	305.5Cr	477.6Cr	403.3Cr	443.1Cr
Total Revenues	7.72TCr	8.42TCr	9.29TCr	11TCr	12TCr
Policy Benefits	6.16TCr	6.92TCr	7.57TCr	8.84TCr	10TCr
Depreciation & Amortization - (IS) - (Collected)	49Cr	60Cr	71Cr	78Cr	84Cr
Selling General & Admin Expenses, Total	1.01TCr	1.01TCr	1.22TCr	1.26TCr	1.32TCr
Total Operating Expenses	7.22TCr	7.99TCr	8.86TCr	10TCr	11TCr
Operating Income	498.6Cr	427.7Cr	427.3Cr	457.4Cr	304.3Cr
Interest Expense, Total	-28Cr	-33Cr	-40Cr	-49Cr	-66Cr
Income (Loss) on Equity Invest.	7.4Cr	6.5Cr	-40L	-6.3Cr	-9.4Cr
Other Non Operating Income (Expenses)	-10Cr	-60Cr	-6.8Cr	-14Cr	-18Cr
EBT, Excl. Unusual Items	467.4Cr	341.9Cr	380Cr	388.1Cr	210.8Cr
Restructuring Charges	-	-	-47Cr	-51Cr	-28Cr
Total Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	24Cr	-	-
Asset Writedown	-	-	-	-5.5Cr	-20Cr
EBT, Incl. Unusual Items	467.4Cr	341.9Cr	356.4Cr	332Cr	162.7Cr
Income Tax Expense	130.7Cr	48Cr	76Cr	84Cr	41Cr
Earnings From Continuing Operations	336.7Cr	293.4Cr	280.2Cr	248.4Cr	121.4Cr
Net Income to Company	336.7Cr	293.4Cr	280.2Cr	248.4Cr	121.4Cr
Minority Interest	-	-10L	40L	50L	-70L
Net Income - (IS)	336.7Cr	293.3Cr	280.6Cr	248.9Cr	120.7Cr
Net Income to Common Incl Extra Items	336.7Cr	293.3Cr	280.6Cr	248.9Cr	120.7Cr
Net Income to Common Excl. Extra Items	336.7Cr	293.3Cr	280.6Cr	248.9Cr	120.7Cr
Per Share Items
Net EPS - Basic	25.47	22.79	22.2	20.09	10.01
Basic EPS - Continuing Operations	25.47	22.79	22.2	20.09	10.01
Basic Weighted Average Shares Outstanding	13Cr	13Cr	13Cr	12Cr	12Cr
Net EPS - Diluted	25.31	22.67	22.08	20	9.98
Diluted EPS - Continuing Operations	25.31	22.67	22.08	20	9.98
Diluted Weighted Average Shares Outstanding	13Cr	13Cr	13Cr	12Cr	12Cr
Normalized Basic EPS	22.1	16.6	18.82	19.62	10.87
Normalized Diluted EPS	21.96	16.51	18.72	19.53	10.84
Dividend Per Share	2.5	2.8	3.15	3.54	3.54
Payout Ratio	9.59	12.07	13.97	21.33	35.71
American Depositary Receipts Ratio (ADR)	0.02	0.02	0.02	0.02	0.02
Supplemental Items
EBITDA	525.1Cr	454.7Cr	459.3Cr	490.2Cr	335.1Cr
EBITA	507.4Cr	435Cr	436.9Cr	464.1Cr	310.3Cr
EBIT	498.6Cr	427.7Cr	427.3Cr	457.4Cr	304.3Cr
EBITDAR	544.8Cr	475.7Cr	482.5Cr	510.1Cr	354.9Cr
Total Revenues (As Reported)	7.72TCr	8.31TCr	9.29TCr	11TCr	12TCr
Effective Tax Rate - (Ratio)	27.96	14.19	21.38	25.18	25.38
Current Domestic Taxes	111.2Cr	47Cr	86Cr	100Cr	60Cr
Total Current Taxes	111.2Cr	47Cr	86Cr	100Cr	60Cr
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	20Cr	1.5Cr	-10Cr	-16Cr	-19Cr
Normalized Net Income	292.12Cr	213.59Cr	237.9Cr	243.06Cr	131.05Cr
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Net Rental Expense, Total	20Cr	21Cr	23Cr	20Cr	20Cr
Imputed Operating Lease Interest Expense	6.46Cr	5.21Cr	5.82Cr	6.37Cr	8.28Cr
Imputed Operating Lease Depreciation	13Cr	16Cr	17Cr	14Cr	12Cr
Stock-Based Comp., Other (Total)	18Cr	18Cr	22Cr	18Cr	21Cr
Total Stock-Based Compensation	18Cr	18Cr	22Cr	18Cr	21Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Investment In Debt Securities	-	-	-	-	-
Investment In Equity and Preferred Securities, Total	117Cr	14Cr	75Cr	74Cr	70Cr
Total Other Investments	1.38TCr	1.4TCr	1.43TCr	1.7TCr	1.86TCr
Total investments	1.49TCr	1.41TCr	1.5TCr	1.77TCr	1.93TCr
Cash And Equivalents	467.3Cr	339.4Cr	506.1Cr	469.4Cr	222.1Cr
Reinsurance Recoverable - (IS)	142Cr	189.4Cr	70Cr	51Cr	120.3Cr
Other Receivables - (Insurance Template)	253.8Cr	381.4Cr	367.4Cr	433.5Cr	270.57Cr
Deferred Policy Acquisition Costs - (BS)	-	-	-	-	-
Gross Property Plant And Equipment	593.1Cr	662.5Cr	687.2Cr	639.4Cr	611.6Cr
Accumulated Depreciation	-312.3Cr	-287.4Cr	-313.6Cr	-285.4Cr	-313.9Cr
Net Property Plant And Equipment	280.8Cr	375.1Cr	373.6Cr	354Cr	297.7Cr
Goodwill	444.7Cr	1.11TCr	914.2Cr	955Cr	963.1Cr
Other Intangibles, Total	33Cr	263.9Cr	176.5Cr	169.3Cr	144.3Cr
Other Current Assets, Total	245.6Cr	259.9Cr	287.1Cr	381.7Cr	547.13Cr
Deferred Tax Assets Long-Term (Collected)	-	-	-	-	-
Other Long-Term Assets, Total	136.2Cr	106.2Cr	110Cr	117.4Cr	149.5Cr
Total Assets	3.5TCr	4.44TCr	4.31TCr	4.71TCr	4.65TCr
Liabilities
Accounts Payable, Total	359.2Cr	379Cr	368.4Cr	436.3Cr	437.3Cr
Insurance And Annuity Liabilities	38Cr	73Cr	148Cr	213.4Cr	80Cr
Unpaid Claims	814.3Cr	828.9Cr	926.4Cr	1.02TCr	1.04TCr
Unearned Premiums	32Cr	25Cr	29Cr	27Cr	26Cr
Current Portion of Long-Term Debt	-	100Cr	149.7Cr	57Cr	58Cr
Current Portion of Leases	13Cr	18Cr	15Cr	15Cr	13Cr
Short-Term Borrowings	92Cr	128.1Cr	89Cr	122.4Cr	40Cr
Long-Term Debt	606Cr	1.05TCr	903.4Cr	1.02TCr	1.11TCr
Long-Term Leases	36Cr	55Cr	46Cr	44Cr	39Cr
Deferred Tax Liability Non-Current	66Cr	70Cr	2.7Cr	4.8Cr	26Cr
Other Non Current Liabilities	68Cr	94Cr	91Cr	109.3Cr	126Cr
Total Liabilities	2.12TCr	2.83TCr	2.77TCr	3.07TCr	3TCr
Common Stock, Total	3.3Cr	3.3Cr	3.3Cr	3.3Cr	3.3Cr
Additional Paid In Capital	270.5Cr	308.2Cr	324.6Cr	334.6Cr	346.3Cr
Retained Earnings	2.05TCr	2.31TCr	2.55TCr	2.75TCr	2.83TCr
Treasury Stock	-991.8Cr	-1.02TCr	-1.22TCr	-1.37TCr	-1.44TCr
Comprehensive Income and Other	39Cr	4.2Cr	-130.4Cr	-100Cr	-106.7Cr
Total Common Equity	1.37TCr	1.61TCr	1.53TCr	1.63TCr	1.64TCr
Minority Interest	-	2.3Cr	5.9Cr	5.6Cr	7Cr
Total Equity	1.37TCr	1.61TCr	1.54TCr	1.63TCr	1.64TCr
Total Liabilities And Equity	3.5TCr	4.44TCr	4.31TCr	4.71TCr	4.65TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13Cr	13Cr	12Cr	12Cr	12Cr
ECS Total Common Shares Outstanding	13Cr	13Cr	12Cr	12Cr	12Cr
Book Value / Share	106.53	124.84	122.51	133.05	135.73
Tangible Book Value	895.2Cr	234.9Cr	440.4Cr	501.9Cr	530.1Cr
Tangible Book Value Per Share	69.47	18.24	35.24	41.06	43.94
Total Debt	746.4Cr	1.36TCr	1.2TCr	1.26TCr	1.26TCr
Net Debt	279.1Cr	1.02TCr	697.1Cr	790.8Cr	1.04TCr
Debt Equivalent Oper. Leases	157.6Cr	168Cr	185.6Cr	159.2Cr	158.4Cr
Minority Interest, Total (Incl. Fin. Div)	-	2.3Cr	5.9Cr	5.6Cr	7Cr
Equity Method Investments, Total	117Cr	14Cr	75Cr	74Cr	70Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	1.9Cr	1.7Cr	1.7Cr	1.6Cr	1.7Cr
Buildings, Total	95Cr	112.6Cr	114.3Cr	100.2Cr	103.8Cr
Machinery, Total	100.9Cr	114.8Cr	124.6Cr	132Cr	140Cr
Full Time Employees	48.7T	95.5T	67.1T	67.6T	65.68T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	336.7Cr	293.3Cr	280.6Cr	248.9Cr	120.7Cr
Depreciation, Depletion & Amortization	18Cr	20Cr	22Cr	26Cr	25Cr
Amortization of Goodwill and Intangible Assets - (CF)	8.8Cr	7.3Cr	9.6Cr	6.7Cr	6Cr
Total Depreciation, Depletion & Amortization	26Cr	27Cr	32Cr	33Cr	31Cr
Amortization of Deferred Charges, Total	35Cr	44Cr	52Cr	59Cr	66Cr
(Gain) Loss On Sale of Asset - (CF)	-	-	-24Cr	-	-
(Gain) Loss on Sale of Investments - (CF)	-84Cr	13Cr	20Cr	5.4Cr	-2.4Cr
Total Asset Writedown	-	-	25Cr	21Cr	44Cr
(Income) Loss On Equity Investments - (CF)	-7.4Cr	-119.4Cr	40L	6.3Cr	9.4Cr
Stock-Based Compensation (CF)	18Cr	18Cr	22Cr	23Cr	21Cr
Provision and Write-off of Bad Debts	-	-	-	-	-
Change in Accounts Receivable	-8.5Cr	-28Cr	-5.4Cr	-34Cr	-67Cr
Change in Unearned Revenues	7.1Cr	-6.5Cr	3.2Cr	-2Cr	-60L
Change in insurance Reserves / Liabilities	213.9Cr	10Cr	98Cr	92Cr	20Cr
Change in Other Net Operating Assets (Collected)	1.8Cr	-32Cr	-42Cr	-48Cr	63Cr
Other Operating Activities	24Cr	5.6Cr	-3.4Cr	-5.9Cr	-7.7Cr
Cash from Operations	563.9Cr	226.2Cr	458.7Cr	398.1Cr	296.6Cr
Capital Expenditure	-96Cr	-131.6Cr	-112Cr	-100.4Cr	-58Cr
Sale of Property, Plant, and Equipment	-	-	-	21Cr	70L
Cash Acquisitions	-71Cr	-418.7Cr	-34Cr	-23Cr	-8.9Cr
Divestitures	-	-	270.1Cr	-	-
Investment in Marketable and Equity Securities, Total	-139.2Cr	-105.3Cr	-225Cr	-246.5Cr	-224.5Cr
Other Investing Activities, Total	-	-	-	-	-5Cr
Cash from Investing	-306.5Cr	-655.6Cr	-100.6Cr	-349.2Cr	-295.2Cr
Short Term Debt Issued, Total	39Cr	36Cr	-	37Cr	47Cr
Long-Term Debt Issued, Total	208.8Cr	548.4Cr	198.2Cr	254.4Cr	223.2Cr
Total Debt Issued	247.8Cr	584.2Cr	198.2Cr	291Cr	270Cr
Short Term Debt Repaid, Total	-	-	-40Cr	-	-91Cr
Long-Term Debt Repaid, Total	-140Cr	-207.8Cr	-300Cr	-233.2Cr	-110.7Cr
Total Debt Repaid	-140Cr	-207.8Cr	-340.4Cr	-233.2Cr	-201.4Cr
Issuance of Common Stock	4.9Cr	2.1Cr	-	-	-
Repurchase of Common Stock	-182Cr	-7.9Cr	-209.6Cr	-157.3Cr	-82Cr
Common Dividends Paid	-32Cr	-35Cr	-39Cr	-53Cr	-43Cr
Common & Preferred Stock Dividends Paid	-32Cr	-35Cr	-39Cr	-53Cr	-43Cr
Annuity Receipts	-	-	-	-	-
Annuity Payments	-94Cr	-31Cr	199.3Cr	83Cr	-193.3Cr
Other Financing Activities, Total	-	-3.1Cr	30L	-16Cr	80L
Cash from Financing	-195.5Cr	301.5Cr	-191.4Cr	-86Cr	-248.7Cr
Net Change in Cash	62Cr	-127.9Cr	166.7Cr	-37Cr	-247.3Cr
Supplemental Items
Cash Interest Paid	26Cr	28Cr	35Cr	39Cr	58Cr
Cash Income Tax Paid (Refund)	113.2Cr	23Cr	76Cr	100Cr	57Cr
Net Debt Issued / Repaid	107.8Cr	376.4Cr	-142.2Cr	58Cr	69Cr
Levered Free Cash Flow	209.44Cr	3.74Cr	450.7Cr	76Cr	-131.06Cr
Unlevered Free Cash Flow	227.12Cr	24Cr	475.76Cr	106.78Cr	-90Cr
Change In Net Working Capital	68Cr	200.9Cr	-214.6Cr	187.9Cr	340Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.73	6.74	6.11	6.34	4.07
Return on Total Capital	15.75	10.51	9.36	10.15	6.56
Return On Equity %	26.14	19.67	17.81	15.68	7.41
Return on Common Equity	26.14	19.68	17.88	15.77	7.4
Margin Analysis
Gross Profit Margin %	20.12	17.81	18.5	16.9	14.52
SG&A Margin	13.03	12.02	13.13	11.87	11.22
EBITDA Margin %	6.81	5.4	4.95	4.61	2.85
EBITA Margin %	6.58	5.17	4.7	4.36	2.63
EBIT Margin %	6.46	5.08	4.6	4.3	2.58
Income From Continuing Operations Margin %	4.36	3.48	3.02	2.34	1.03
Net Income Margin %	4.36	3.48	3.02	2.34	1.02
Net Avail. For Common Margin %	4.36	3.48	3.02	2.34	1.02
Normalized Net Income Margin	3.79	2.54	2.56	2.28	1.11
Levered Free Cash Flow Margin	2.71	0.04	4.85	0.71	-1.11
Unlevered Free Cash Flow Margin	2.94	0.29	5.12	1	-0.76
Asset Turnover
Asset Turnover	2.41	2.12	2.12	2.36	2.52
Fixed Assets Turnover	29.83	25.67	24.81	29.24	36.14
Receivables Turnover (Average Receivables)	67.91	54.29	50.63	55.21	47.82
Short Term Liquidity
Current Ratio	1.77	1.62	1.52	1.59	1.76
Quick Ratio	1.48	1.33	1.32	1.36	1.37
Operating Cash Flow to Current Liabilities	0.42	0.15	0.27	0.21	0.18
Days Sales Outstanding (Average Receivables)	5.39	6.72	7.21	6.61	7.65
Average Days Payable Outstanding	64.34	64.98	65.01	64.03	58.59
Long Term Solvency
Total Debt/Equity	54.37	84.15	78.28	77.23	76.9
Total Debt / Total Capital	35.22	45.7	43.91	43.58	43.47
LT Debt/Equity	46.73	68.85	61.74	65.31	70.15
Long-Term Debt / Total Capital	30.27	37.39	34.63	36.85	39.65
Total Liabilities / Total Assets	60.74	63.7	64.3	65.33	64.62
EBIT / Interest Expense	17.62	13.12	10.66	9.28	4.61
EBITDA / Interest Expense	19.25	14.59	12.03	10.35	5.38
(EBITDA - Capex) / Interest Expense	15.84	10.56	9.24	8.31	4.51
Total Debt / EBITDA	1.37	2.85	2.49	2.47	3.56
Net Debt / EBITDA	0.51	2.14	1.44	1.55	2.94
Total Debt / (EBITDA - Capex)	1.66	3.94	3.25	3.08	4.25
Net Debt / (EBITDA - Capex)	0.62	2.95	1.88	1.93	3.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.9	9.12	10.31	14.54	10.7
Gross Profit, 1 Yr. Growth %	40.76	-3.43	14.58	4.66	-4.91
EBITDA, 1 Yr. Growth %	51.28	-13.41	1.01	6.73	-32.14
EBITA, 1 Yr. Growth %	53.34	-14.27	0.44	6.23	-33.65
EBIT, 1 Yr. Growth %	53.94	-14.22	-0.09	7.04	-33.99
Earnings From Cont. Operations, 1 Yr. Growth %	24.38	-12.86	-4.5	-11.35	-51.13
Net Income, 1 Yr. Growth %	24.38	-12.89	-4.33	-11.3	-51.51
Normalized Net Income, 1 Yr. Growth %	32.9	-26.88	11.38	2.17	-46.58
Diluted EPS Before Extra, 1 Yr. Growth %	25.92	-10.43	-2.6	-9.42	-50.1
Net Property, Plant and Equip., 1 Yr. Growth %	18.73	33.58	-0.4	-5.25	-15.9
Accounts Receivable, 1 Yr. Growth %	7.77	59.4	-7.72	21.57	32.87
Total Assets, 1 Yr. Growth %	20.28	26.85	-2.94	9.31	-1.25
Common Equity, 1 Yr. Growth %	14.05	17.13	-4.78	6.21	0.69
Tangible Book Value, 1 Yr. Growth %	12.86	-73.76	87.48	13.96	5.62
Cash From Operations, 1 Yr. Growth %	6.72	-59.89	102.79	-13.21	-25.5
Capital Expenditures, 1 Yr. Growth %	30.98	36.51	-14.89	-11.7	-42.73
Levered Free Cash Flow, 1 Yr. Growth %	-9.85	-98.22	11.96T	-83.08	-267.57
Unlevered Free Cash Flow, 1 Yr. Growth %	-8.21	-89.38	1.87T	-77.48	-182.38
Dividend Per Share, 1 Yr. Growth %	13.64	12	12.5	12.38	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.43	13.91	9.71	13.16	12.61
Gross Profit, 2 Yr. CAGR %	18.65	16.59	5.19	13.88	-0.24
EBITDA, 2 Yr. CAGR %	25.46	15.24	-6.48	19.76	-14.58
EBITA, 2 Yr. CAGR %	26.12	15.48	-7.21	20.04	-15.72
EBIT, 2 Yr. CAGR %	26.58	15.75	-7.43	20.54	-15.61
Earnings From Cont. Operations, 2 Yr. CAGR %	41.44	4.11	-8.78	-7.99	-34.18
Net Income, 2 Yr. CAGR %	41.44	4.09	-8.71	-7.88	-34.41
Normalized Net Income, 2 Yr. CAGR %	27.57	-0.76	-9.76	6.68	-25.78
Diluted EPS Before Extra, 2 Yr. CAGR %	44.27	6.2	-6.6	-6.07	-32.77
Net Property, Plant and Equip., 2 Yr. CAGR %	27.22	25.94	15.35	-2.85	-10.73
Accounts Receivable, 2 Yr. CAGR %	5.89	31.06	21.28	5.92	27.09
Total Assets, 2 Yr. CAGR %	17.3	23.52	10.96	3.01	3.9
Common Equity, 2 Yr. CAGR %	16.23	15.58	5.61	0.56	3.42
Tangible Book Value, 2 Yr. CAGR %	21.95	-45.58	-29.86	46.17	9.71
Cash From Operations, 2 Yr. CAGR %	61.09	-34.57	-9.81	32.66	-19.59
Capital Expenditures, 2 Yr. CAGR %	25.51	33.72	7.79	-13.51	-28.89
Levered Free Cash Flow, 2 Yr. CAGR %	167.7	-87.24	46.7	4.6	-45.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	281.57	-68.6	44.73	47.54	-56.47
Dividend Per Share, 2 Yr. CAGR %	11.8	12.82	12.25	12.44	6.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.79	13.94	12.69	11.3	12.34
Gross Profit, 3 Yr. CAGR %	14.77	10.78	15.91	5.01	7.23
EBITDA, 3 Yr. CAGR %	12.66	10.87	10.29	-2.27	-0.66
EBITA, 3 Yr. CAGR %	12.65	10.89	10.23	-2.93	-1.24
EBIT, 3 Yr. CAGR %	12.8	11.18	10.21	-2.83	-1.12
Earnings From Cont. Operations, 3 Yr. CAGR %	11.21	20.35	1.16	-9.64	-25.48
Net Income, 3 Yr. CAGR %	11.21	20.34	1.2	-9.58	-25.62
Normalized Net Income, 3 Yr. CAGR %	13.09	5.97	3.13	-5.94	-15.03
Diluted EPS Before Extra, 3 Yr. CAGR %	14.62	23.08	3.18	-7.55	-23.93
Net Property, Plant and Equip., 3 Yr. CAGR %	21.03	29.31	16.46	8.03	-7.41
Accounts Receivable, 3 Yr. CAGR %	10.04	21.35	16.6	21.38	14.23
Total Assets, 3 Yr. CAGR %	8.76	20.4	13.98	10.41	1.57
Common Equity, 3 Yr. CAGR %	11.73	16.53	8.35	5.81	0.61
Tangible Book Value, 3 Yr. CAGR %	12.22	-26.92	-17.81	-17.54	31.17
Cash From Operations, 3 Yr. CAGR %	11.66	1.35	-4.61	-10.96	9.45
Capital Expenditures, 3 Yr. CAGR %	22.53	29.07	15.02	1.36	-24.61
Levered Free Cash Flow, 3 Yr. CAGR %	-10.24	-49.62	25.25	-28.68	23.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	-9.33	15.62	24.84	-22.24	22.34
Dividend Per Share, 3 Yr. CAGR %	16.04	11.87	12.71	12.29	8.13
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.28	9.14	11.55	13.33	12.66
Gross Profit, 5 Yr. CAGR %	9.16	9.85	10.84	10.27	9.16
EBITDA, 5 Yr. CAGR %	15.12	17.21	4.58	8	-0.43
EBITA, 5 Yr. CAGR %	15.55	17.75	4.24	7.79	-0.99
EBIT, 5 Yr. CAGR %	16.04	18.31	4.23	8.01	-0.95
Earnings From Cont. Operations, 5 Yr. CAGR %	21.42	36.73	2.74	8.1	-14.82
Net Income, 5 Yr. CAGR %	21.42	36.72	2.77	8.14	-14.92
Normalized Net Income, 5 Yr. CAGR %	16.44	15.59	3.33	6.25	-9.58
Diluted EPS Before Extra, 5 Yr. CAGR %	24.56	40.98	5.61	10.46	-13.07
Net Property, Plant and Equip., 5 Yr. CAGR %	15.2	20.04	18.72	15.33	4.71
Accounts Receivable, 5 Yr. CAGR %	-0.4	7.22	14.41	14.93	20.69
Total Assets, 5 Yr. CAGR %	7.22	11.8	9.64	13.12	9.84
Common Equity, 5 Yr. CAGR %	5.82	8.52	9.24	9.86	6.35
Tangible Book Value, 5 Yr. CAGR %	5.89	-19.92	-7.01	-3.57	-7.74
Cash From Operations, 5 Yr. CAGR %	45.39	3.16	2.52	12.87	-10.91
Capital Expenditures, 5 Yr. CAGR %	13.01	20.09	16.41	10.41	-4.82
Levered Free Cash Flow, 5 Yr. CAGR %	-1.63	-53.25	9.25	21.05	-10.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.02	-33.04	9.32	46.92	-18.15
Dividend Per Share, 5 Yr. CAGR %	16.8	19.27	14.51	12.1	9.98